Status:
COMPLETED
Fast VT Episodes Are Terminated by ATP One Shot
Lead Sponsor:
Biotronik SE & Co. KG
Conditions:
Ventricular Tachycardia, Monomorphic
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Many arrhythmias detected in the ventricular fibrillation (VF)-zone picture monomorphic ventricular tachycardia (VT) and, hence, could be terminated by antitachycardia pacing (ATP) treatment. Advantag...
Detailed Description
ICDs provide different detection zones for the therapy of VT and VF. An established form of therapy in the VT-zone is antitachycardia pacing (ATP). It is an effective, safe and painless method to term...
Eligibility Criteria
Inclusion
- ICD indication for reason of survived cardiac arrest, ventricular tachycardia or syncope
Exclusion
- ICD indication for reason of non-sustained VT post MI, positive family history for SCD (Brugada-, long/short QT-Syndrome), hypertrophic cardiomyopathy, primary prophylactic indication (e.g. SCD-HeFT, Madit II)
- Patients not capable of participating in the follow-ups
- Minors and pregnant women
- Patients who are already enrolled in another study
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT00617578
Start Date
November 1 2007
End Date
July 1 2012
Last Update
December 19 2013
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Abteilung, LKH Bruck
Bruck / Mur, Austria, 8600
2
Innere Medizin - Kardiologie, Universitätsklinik Innsbruck
Innsbruck, Austria, 6020
3
Med. Abteilung, AKH Linz
Linz, Austria, 4020
4
Cardiology, Satakunta Central Hospital
Pori, Finland, 28100